Merger

A private market index tracking tech giants like SpaceX surged nearly 200% in 14 months, raising questions about a new, exclusive tier of wealth creation.

As Evolus presents at a key healthcare conference, investors watch to see if its new filler line and digital strategy can deliver on bold promises.

The bank's Q1 earnings surge to $1.25B, driven by its Canadian Western Bank takeover and strategic deals, signaling aggressive pan-Canadian expansion.

Amid private credit turmoil, SLR Investment Corp. posts solid 2025 results, leveraging a strategic pivot to asset-based lending for stability and returns.

North American logistics giant TFI International expands its dedicated services by acquiring Benchmark Logistics and Triangle Warehouse in a key Midwest deal.

Euroholdings declared a dividend on solid Q4 results, but a $10.2M one-time gain skews its full-year profits as it bets big on the tanker market.

A new giant enters the AI arena. Brookfield launches Radiant to build global 'AI factories,' challenging cloud titans and fueling the race for sovereign AI.

With a record $1.2B order backlog and a bullish 2026 forecast, the specialty vehicle maker also announces a major leadership shift to drive its next growth phase.

The coffee giant posts impressive 2025 results amid high inflation, paving the way for its blockbuster acquisition by Keurig Dr Pepper. What's next?

A former hedge fund manager's stark video presentation warns that AI will permanently alter work and wealth. Are American workers prepared for what's next?

CAVU Consumer Partners promotes Jared Jacobs, signaling a deeper focus on its founder-first strategy in the booming pet, nutrition, and wellness sectors.

Biomerics appoints manufacturing veteran Tyler Reed to lead its Micro Metals Division, a strategic move to optimize recent acquisitions and dominate the market.

With a novel skin drug launched, Pelthos Therapeutics heads to a key conference. Can its focused strategy convince Wall Street of its blockbuster potential?

After halting all R&D, PCI Biotech proposes dissolution and delisting, marking the end for its novel drug delivery platform and a warning for investors.

Following a series of acquisitions, Southwest Strategies Group rebrands as Bodewell, positioning itself to manage public consent for a new era of US infrastructure.

The biotech firm slashed a major acquisition hurdle in a deal with HealthCare Royalty, signaling strong confidence in its cancer drug ZYNLONTA's future.

Investors eye BBVA Argentina's upcoming FY2025 report for insights into its resilience and growth against a backdrop of high inflation and policy changes.

Xtreme One Entertainment's OTCQB uplist signals a new era for its XFC brand, aiming to boost investor trust and fund its 'minor league' MMA growth.

Cloud security leader Zscaler prepares for high-stakes investor conferences, aiming to showcase its financial strength and AI-driven growth strategy.

Leo's strategic investment unites two engineering firms, adding nearly 300 experts to challenge national facilities management leaders.